Related Experiment Video

Updated: Mar 23, 2026

In Vitro Transcription Assays and Their Application in Drug Discovery
09:28

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

15.8K

Structural basis for inhibition of the deadenylase activity of human CNOT6L

Qionglin Zhang1, Dongke Yan1,2, Erhong Guo1,2

  • 1College of Life Sciences, Nankai University, Tianjin, China.

FEBS Letters
|March 26, 2016
PubMed

Insights

Human CNOT6L deadenylase inhibitors, including nucleotides like AMP and neomycin, bind to its active site. These findings reveal how inhibitors interact with the CCR4-NOT complex, impacting deadenylation processes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • CNOT6L/CCR4 is a key deadenylase enzyme within the CCR4-NOT complex, crucial for regulating mRNA stability.
  • The CCR4-NOT complex plays a vital role in post-transcriptional gene regulation through mRNA deadenylation.

Discussion:

  • This study presents crystal structures of the human CNOT6L nuclease domain bound to CMP and neomycin.
  • The structures reveal that both CMP and neomycin bind to the substrate and magnesium-ion binding sites.
  • This competitive binding mechanism suggests a shared active site for substrates and inhibitors.

Key Insights:

  • Nucleotides, particularly AMP, are effective inhibitors of CNOT6L and CNOT7 deadenylase activity.
  • Neomycin demonstrates weak inhibitory effects on deadenylase activity.
  • Inhibitors compete with both the substrate and essential divalent magnesium ions for binding within the CNOT6L active site.

Outlook:

  • Understanding these inhibitor-binding mechanisms can inform the design of more potent and specific CNOT6L/CCR4 modulators.
  • Further research could explore the therapeutic potential of targeting deadenylase activity in diseases associated with mRNA dysregulation.
  • Structural insights into inhibitor interactions provide a foundation for developing novel biochemical tools to study deadenylation pathways.
Keywords:
CCR4-NOT complexcrystal structuredeadenylaseinhibitor

More Related Videos

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD108:17

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1

Published on: April 16, 2021

3.0K
Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication05:33

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

1.6K

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.1K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.7K